Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

142 trials

NCT06323681
Recruiting
Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study）
Not applicable · China · 1 site
Registry update: 21 Mar 2024
NCT06874127
Recruiting
Non-Invasive Model for Fibrosis Regression in HBV Patients
Not applicable · China · 1 site
Registry update: 13 Mar 2025
NCT06779864
Recruiting
Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance
Not applicable · China · 1 site
Registry update: 17 Jan 2025
NCT07137247
Recruiting
Immune Dynamics in the Natural History of Chronic HBV Infection
Not applicable · China · 1 site
Registry update: 30 Sept 2025
NCT06525909
Recruiting
A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B
Not applicable · China · 5 sites
Registry update: 29 Jul 2024
NCT06368882
Recruiting
Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）
Phase 4 · China · 5 sites
Registry update: 16 Apr 2024
NCT06263959
Recruiting
A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
Phase 2 · China · 1 site
Registry update: 5 Mar 2025
NCT06084234
Recruiting
National Liver Cancer Screening Trial
Phase 4 · United States · 19 sites
Registry update: 25 Sept 2026
NCT05832229
Recruiting
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Phase 2 · United States · 13 sites
Registry update: 28 Sept 2026
NCT06906016
Recruiting
New HBV Infection Biomarkers: Clinical Characterization and Impact on Management
Not applicable · France · 1 site
Registry update: 2 Apr 2025
NCT05583006
Recruiting
Tenofovir Alafenamide Switch Therapy in Chronic Hepatitis B
Not applicable · Taiwan · 1 site
Registry update: 9 Jan 2025
NCT05771402
Recruiting
A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)
Phase 2 · China · 1 site
Registry update: 4 Sept 2026
NCT07852091
Recruiting
A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (A)
Phase 2 · China · 1 site
Registry update: 1 Oct 2026
NCT07845058
Recruiting
A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (B)
Phase 2 · China · 1 site
Registry update: 28 Sept 2026
NCT05769816
Recruiting
A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)
Phase 2 · China · 1 site
Registry update: 22 Sept 2026
NCT05905172
Recruiting
Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
Phase 3 · China · 23 sites
Registry update: 4 Jun 2025
NCT05988879
Recruiting
Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients
Not applicable · China · 1 site
Registry update: 14 Aug 2023
NCT05922306
Recruiting
Efficacy of NA Combined With PEG-IFN-α2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B
Early phase 1 · China · 1 site
Registry update: 28 Jun 2023
NCT06746701
Recruiting
Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA.
Not applicable · China · 4 sites
Registry update: 24 Dec 2024
NCT05977283
Recruiting
HBsAg Declined Patients Follow-up Study
Not applicable · China · 1 site
Registry update: 20 Feb 2024

Ordered by registry start date. Freshness and sponsorship never change the order.